Mankind Pharma

{
  "main_header": {
    "sid": 1003845,
    "name": "Mankind Pharma",
    "stock_name": "Mankind Pharma",
    "full_name": "Mankind Pharma Ltd",
    "name_url": "stocks-analysis/mankind-pharma",
    "exchange": 1,
    "exchangecode": "",
    "primexch": 1,
    "country_id": 34,
    "currency": "INR",
    "cmp": "2,469.60",
    "chg": -106.3,
    "chgp": "-4.13%",
    "dir": -1,
    "prev_price": "2,575.90",
    "mcapval": "100,971.00 Cr",
    "mcap": "Mid Cap",
    "scripcode": 543904,
    "symbol": "MANKIND",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 4,
    "sector_id": 65,
    "indexname": "India SENSEX",
    "isin": "INE634S01028",
    "curr_date": "Jul 31, 03:30 PM",
    "curr_time": "18:41 PM",
    "last_traded_at": "Jul 31, 03:30 PM IST",
    "bse_nse_vol": "24.74 lacs",
    "exc_status": "Active",
    "traded_date": "Jul 31, 2026",
    "traded_date_str": "2026 07 31",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-register-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/mankind-pharma-1003845-1&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0
    }
  },
  "news": {
    "results": [
      {
        "title": "Mankind Pharma Sees Sharp Open Interest Surge Amid Volatile Trading",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/mankind-pharma-sees-sharp-open-interest-surge-amid-volatile-trading-4130502",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/7/MankindPharmaLt_oi_spurts_by_underlying_4130502.png",
        "date": "2026-07-31 15:00:23",
        "description": "Mankind Pharma Ltd has witnessed a significant surge in open interest in its derivatives segment, signalling heightened market activity and shifting investor positioning. Despite a recent price decline, the pharmaceutical company’s futures and options contracts have attracted increased volumes, reflecting a complex interplay of directional bets and volatility."
      },
      {
        "title": "Mankind Pharma Sees Sharp Open Interest Surge Amid Volatile Trading",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/mankind-pharma-sees-sharp-open-interest-surge-amid-volatile-trading-4130452",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/7/MankindPharmaLt_oi_spurts_by_underlying_4130452.png",
        "date": "2026-07-31 14:00:17",
        "description": "Mankind Pharma Ltd, a mid-cap player in the Pharmaceuticals & Biotechnology sector, witnessed a significant surge in open interest (OI) in its derivatives segment, signalling heightened market activity and shifting investor positioning. Despite a recent price decline, the stock’s derivatives market reveals intriguing directional bets that merit close attention from investors and analysts alike."
      },
      {
        "title": "Mankind Pharma Ltd Sees Sharp Open Interest Surge Amid Volatile Trading",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/mankind-pharma-ltd-sees-sharp-open-interest-surge-amid-volatile-trading-4130397",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/7/MankindPharmaLt_oi_spurts_by_underlying_4130397.png",
        "date": "2026-07-31 13:00:14",
        "description": "Mankind Pharma Ltd, a mid-cap player in the Pharmaceuticals & Biotechnology sector, witnessed a significant surge in open interest (OI) in its derivatives segment, signalling heightened market activity and shifting investor positioning. Despite a recent price decline, the stock’s derivatives market shows signs of increased speculative interest, raising questions about potential directional bets and future price movements."
      },
      {
        "title": "Mankind Pharma Sees Sharp Open Interest Surge Amid Volatile Trading",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/mankind-pharma-sees-sharp-open-interest-surge-amid-volatile-trading-4130354",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/7/MankindPharmaLt_oi_spurts_by_underlying_4130354.png",
        "date": "2026-07-31 12:00:14",
        "description": "Mankind Pharma Ltd has witnessed a significant surge in open interest in its derivatives segment, signalling heightened market activity and shifting investor positioning. Despite a recent price decline, the pharmaceutical company’s futures and options contracts have attracted increased volumes, reflecting a complex interplay of directional bets and volatility in the stock."
      },
      {
        "title": "Mankind Pharma Sees Sharp Open Interest Surge Amid Volatile Trading",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/mankind-pharma-sees-sharp-open-interest-surge-amid-volatile-trading-4130268",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/7/MankindPharmaLt_oi_spurts_by_underlying_4130268.png",
        "date": "2026-07-31 11:00:12",
        "description": "Mankind Pharma Ltd has witnessed a significant surge in open interest in its derivatives segment, signalling heightened market activity and shifting investor positioning. Despite a recent price decline and increased volatility, the pharmaceutical company’s futures and options contracts have attracted substantial volume, reflecting evolving directional bets and strategic plays by market participants."
      },
      {
        "title": "Mankind Pharma Sees Sharp Open Interest Surge Amid Volatile Trading",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/mankind-pharma-sees-sharp-open-interest-surge-amid-volatile-trading-4129863",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/7/MankindPharmaLt_oi_spurts_by_underlying_4129863.png",
        "date": "2026-07-31 10:00:07",
        "description": "Mankind Pharma Ltd has witnessed a significant surge in open interest in its derivatives segment, signalling heightened market activity and shifting investor positioning. Despite a recent price decline, the pharmaceutical company’s futures and options contracts have seen a 16.8% increase in open interest, reflecting growing speculative interest and potential directional bets amid volatile trading conditions."
      },
      {
        "title": "Mankind Pharma Ltd Hits Intraday Low Amid Price Pressure on 31 Jul 2026",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/mankind-pharma-ltd-hits-intraday-low-amid-price-pressure-on-31-jul-2026-4129779",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/7/MankindPharmaLt_priceRelatedfactors_4129779.png",
        "date": "2026-07-31 09:33:50",
        "description": "Mankind Pharma Ltd experienced a notable decline today, touching an intraday low of Rs 2445.45, reflecting a 5.1% drop as the stock faced significant price pressure and heightened volatility within the Pharmaceuticals & Biotechnology sector."
      },
      {
        "title": "Mankind Pharma Q1 FY27: Strong Revenue Growth Masks Margin Pressures",
        "link": "https://www.marketsmojo.com/news/result-analysis/mankind-pharma-q1-fy27-strong-revenue-growth-masks-margin-pressures-4129164",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/7/MankindPharma_quaterlyResult_4129164.png",
        "date": "2026-07-30 21:18:28",
        "description": "Mankind Pharma Ltd., one of India's leading pharmaceutical companies with a market capitalisation of ₹1,06,503 crores, reported consolidated net profit of ₹568.06 crores for Q1 FY27 ended June 2026, marking a modest sequential growth of 2.47% from ₹554.35 crores in Q4 FY26. On a year-on-year basis, the company delivered impressive growth of 29.60%, substantially outpacing the ₹438.32 crores posted in Q1 FY26. However, the stock reacted negatively, declining 0.60% to ₹2,576.95 following the results announcement, as investors digested margin compression concerns despite robust topline expansion."
      },
      {
        "title": "Mankind Pharma Sees Significant Open Interest Surge Amid Mixed Price Action",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/mankind-pharma-sees-significant-open-interest-surge-amid-mixed-price-action-4128913",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/7/MankindPharmaLt_oi_spurts_by_underlying_4128913.png",
        "date": "2026-07-30 15:00:24",
        "description": "Mankind Pharma Ltd, a mid-cap player in the Pharmaceuticals & Biotechnology sector, has witnessed a notable 15.2% surge in open interest in its derivatives segment, signalling increased market participation and potential shifts in investor positioning despite a modest price decline over recent sessions."
      }
    ],
    "total": 578,
    "sid": "1003845",
    "stock_news_url": "https://www.marketsmojo.com/news/mankind-pharma-1003845"
  },
  "announcements": "",
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "",
      "data": [
        {
          "txt": "Mankind Pharma Ltd has declared <strong>100%</strong> dividend, ex-date: 08 Aug 25",
          "dt": "2025-08-08",
          "middle_text": "Dividend Alert"
        }
      ]
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "No <strong>Splits</strong> history available",
      "data": []
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "No <strong>Bonus</strong> history available",
      "data": []
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}

News and Views

Mankind Pharma Sees Sharp Open Interest Surge Amid Volatile Trading

2026-07-31 15:00:23

Mankind Pharma Ltd has witnessed a significant surge in open interest in its derivatives segment, signalling heightened market activity and shifting investor positioning. Despite a recent price decline, the pharmaceutical company’s futures and options contracts have attracted increased volumes, reflecting a complex interplay of directional bets and volatility.

Read full news article

Mankind Pharma Sees Sharp Open Interest Surge Amid Volatile Trading

2026-07-31 14:00:17

Mankind Pharma Ltd, a mid-cap player in the Pharmaceuticals & Biotechnology sector, witnessed a significant surge in open interest (OI) in its derivatives segment, signalling heightened market activity and shifting investor positioning. Despite a recent price decline, the stock’s derivatives market reveals intriguing directional bets that merit close attention from investors and analysts alike.

Read full news article

Mankind Pharma Ltd Sees Sharp Open Interest Surge Amid Volatile Trading

2026-07-31 13:00:14

Mankind Pharma Ltd, a mid-cap player in the Pharmaceuticals & Biotechnology sector, witnessed a significant surge in open interest (OI) in its derivatives segment, signalling heightened market activity and shifting investor positioning. Despite a recent price decline, the stock’s derivatives market shows signs of increased speculative interest, raising questions about potential directional bets and future price movements.

Read full news article

Mankind Pharma Sees Sharp Open Interest Surge Amid Volatile Trading

2026-07-31 12:00:14

Mankind Pharma Ltd has witnessed a significant surge in open interest in its derivatives segment, signalling heightened market activity and shifting investor positioning. Despite a recent price decline, the pharmaceutical company’s futures and options contracts have attracted increased volumes, reflecting a complex interplay of directional bets and volatility in the stock.

Read full news article

Mankind Pharma Sees Sharp Open Interest Surge Amid Volatile Trading

2026-07-31 11:00:12

Mankind Pharma Ltd has witnessed a significant surge in open interest in its derivatives segment, signalling heightened market activity and shifting investor positioning. Despite a recent price decline and increased volatility, the pharmaceutical company’s futures and options contracts have attracted substantial volume, reflecting evolving directional bets and strategic plays by market participants.

Read full news article

Mankind Pharma Sees Sharp Open Interest Surge Amid Volatile Trading

2026-07-31 10:00:07

Mankind Pharma Ltd has witnessed a significant surge in open interest in its derivatives segment, signalling heightened market activity and shifting investor positioning. Despite a recent price decline, the pharmaceutical company’s futures and options contracts have seen a 16.8% increase in open interest, reflecting growing speculative interest and potential directional bets amid volatile trading conditions.

Read full news article

Mankind Pharma Ltd Hits Intraday Low Amid Price Pressure on 31 Jul 2026

2026-07-31 09:33:50

Mankind Pharma Ltd experienced a notable decline today, touching an intraday low of Rs 2445.45, reflecting a 5.1% drop as the stock faced significant price pressure and heightened volatility within the Pharmaceuticals & Biotechnology sector.

Read full news article

Mankind Pharma Q1 FY27: Strong Revenue Growth Masks Margin Pressures

2026-07-30 21:18:28

Mankind Pharma Ltd., one of India's leading pharmaceutical companies with a market capitalisation of ₹1,06,503 crores, reported consolidated net profit of ₹568.06 crores for Q1 FY27 ended June 2026, marking a modest sequential growth of 2.47% from ₹554.35 crores in Q4 FY26. On a year-on-year basis, the company delivered impressive growth of 29.60%, substantially outpacing the ₹438.32 crores posted in Q1 FY26. However, the stock reacted negatively, declining 0.60% to ₹2,576.95 following the results announcement, as investors digested margin compression concerns despite robust topline expansion.

Read full news article

Mankind Pharma Sees Significant Open Interest Surge Amid Mixed Price Action

2026-07-30 15:00:24

Mankind Pharma Ltd, a mid-cap player in the Pharmaceuticals & Biotechnology sector, has witnessed a notable 15.2% surge in open interest in its derivatives segment, signalling increased market participation and potential shifts in investor positioning despite a modest price decline over recent sessions.

Read full news article

View All News